(Q24242993)

https://api.crossref.org/works/10.1002%2F14651858.CD000181.PUB3

Early ribavirin treatment of respiratory syncytial viral infection in high-risk children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000181.PUB3

Ribavirin in ventilated respiratory syncytial virus bronchiolitis. A randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000181.PUB3

Aerosolized ribavirin treatment of infants with respiratory syncytial viral infection. A randomized double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000181.PUB3

Ribavirin treatment of respiratory syncytial viral infection in infants with underlying cardiopulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000181.PUB3

Respiratory system mechanics in patients receiving aerosolized ribavirin during mechanical ventilation for suspected respiratory syncytial viral infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000181.PUB3

Prospective follow-up and pulmonary functions from a placebo-controlled randomized trial of ribavirin therapy in respiratory syncytial virus bronchiolitis. Ribavirin Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000181.PUB3

A controlled trial of aerosolized ribavirin in infants receiving mechanical ventilation for severe respiratory syncytial virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000181.PUB3

Early ribavarin treatment of bronchiolitis: effect on long-term respiratory morbidity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000181.PUB3

High-dose, short-duration ribavirin aerosol therapy compared with standard ribavirin therapy in children with suspected respiratory syncytial virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000181.PUB3

The effect of ribavirin to treat previously healthy infants admitted with acute bronchiolitis on acute and chronic respiratory morbidity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000181.PUB3

Antiviral therapy in neonatal chronic lung disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000181.PUB3

Long term follow-up of children hospitalized with respiratory syncytial virus lower respiratory tract infection and randomly treated with ribavirin or placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000181.PUB3

Effect of ribavirin therapy on respiratory syncytial virus-specific IgE and IgA responses after infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000181.PUB3

Identifying relevant studies for systematic reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000181.PUB3

Safety issues related to the administration of ribavirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000181.PUB3

Ribavirin therapy for acute bronchiolitis: need for appropriate controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000181.PUB3

Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000181.PUB3

Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) prospective study of risk factors and outcomes in patients hospitalized with respiratory syncytial viral lower respiratory tract infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000181.PUB3

Ribavirin for severe RSV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000181.PUB3

7 January 2021

Aerosolized ribavirin in mechanically ventilated children with respiratory syncytial virus lower respiratory tract disease: a prospective, double-blind, randomized trial.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000181.PUB3

7 January 2021

Ribavirin effect on pulmonary function in young infants with respiratory syncytial virus bronchiolitis.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000181.PUB3

7 January 2021

Bronchoconstrictive effect of ultrasonic nebulized distilled water on asthmatic children

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000181.PUB3

7 January 2021

10.1002/14651858.CD000181.PUB3

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

release_4ykj4ygel5de3bns2b6oshbv54

2996187

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/4ykj4ygel5de3bns2b6oshbv54

24 November 2022

mapped directly with Wikidata item

2996187

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference